Form 4: Cintas Director Scaminace Receives Equity Grant

Cintas Corp. Director Joseph Scaminace was granted 503 restricted shares and 1,694 stock options under the company's equity incentive plan.

Summary

• Joseph Scaminace, a Director of Cintas Corp. (CTAS), reported the acquisition of equity securities.
• On October 29, 2025, Scaminace was granted 503 shares of Common Stock at a price of $0 per share.
• These restricted shares were granted pursuant to Cintas Corporation's 2016 Amended and Restated Equity and Incentive Plan and will cliff vest on the first anniversary of the grant date.
• Following this transaction, Scaminace beneficially owns 43,596 shares of Common Stock.
• Additionally, on October 29, 2025, Scaminace was granted 1,694 stock options (Right to Buy) with an exercise price of $183.9 per share.
• These options were also granted under the 2016 Amended and Restated Equity and Incentive Plan, will cliff vest on the first anniversary of the grant date, and expire on October 29, 2035.
• Following this transaction, Scaminace beneficially owns 1,694 stock options.

Sentiment

Score: 7

Explanation: The filing reports a routine equity compensation grant to a director, which is generally viewed positively as it aligns the director's interests with shareholders. It does not indicate any negative operational or financial news.

Positives

• The equity grants align the director's financial interests with those of the shareholders, encouraging long-term value creation.
• The grants are part of a structured equity and incentive plan, indicating a standard approach to executive compensation.

Negatives

• The transaction represents a grant of equity rather than an open market purchase by the director, meaning there was no direct cash investment by the insider.

Risks

• The value of the granted restricted shares and stock options is subject to market fluctuations of Cintas Corp.'s common stock.
• The benefits from these grants are contingent on the shares and options vesting, which requires continued service for one year from the grant date.

Future Outlook

The grants are structured to incentivize long-term performance, with both restricted shares and stock options scheduled to cliff vest on the first anniversary of the grant date, aligning the director's future compensation with the company's stock performance.

Industry Context

Equity grants to directors and executives are a common practice across industries, serving as a key component of compensation packages designed to align management's interests with shareholder value creation. Cintas's use of its 2016 Equity and Incentive Plan for these grants is consistent with typical corporate governance and compensation strategies.

Comparison to Industry Standards

• The use of restricted stock and stock options as part of director compensation is a standard practice, comparable to compensation structures seen in many large publicly traded companies.
• The vesting schedule, a one-year cliff vest, is a common mechanism to ensure retention and align long-term interests, similar to practices at peers like Aramark (ARMK) or UniFirst (UNF) in the uniform and facility services industry, though specific terms can vary.

Corporate Governance

Stakeholder Impact

• Shareholders: The grants align the director's interests with shareholder value, potentially leading to more focused long-term decision-making.
• Management/Director: Joseph Scaminace receives additional equity compensation, increasing his stake in the company's future performance.

Next Steps

• The restricted shares and stock options will cliff vest on October 29, 2026, subject to the director's continued service.

Key Dates

Recommendation

The filing reports a routine equity grant to a director, which is a standard compensation practice. While it aligns management interests with shareholders, it does not provide new fundamental information or a significant change in the company's outlook that would warrant an immediate change in investment recommendation.

Keywords

Cintas, CTAS, Form 4, Insider Transaction, Equity Grant, Stock Options, Restricted Stock, Joseph Scaminace, Director Compensation